Could skipping antibiotics before bladder botox be safe? new trial aims to find out
NCT ID NCT05534399
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether it is safe to avoid antibiotics before bladder Botox injections in people with multiple sclerosis or spinal cord injury who have bacteria in their urine but no symptoms. About 526 participants will be randomly assigned to receive either antibiotics or no antibiotics around the time of the procedure. The goal is to see if skipping antibiotics leads to more urinary tract infections in the six weeks after the injection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
antibiotic therapy (or no antibiotic therapy)
What this could lead to
If successful, this could show that many patients can safely avoid antibiotics before bladder Botox injections, reducing antibiotic overuse and side effects.
What could go wrong
This is a relatively small, early-stage trial. It may find that skipping antibiotics increases the risk of symptomatic urinary tract infections, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hop Claude Huriez Chu Lille
Lille, 59037, France
Contact Phone: •••-•••-••••